Answers are grounded in this paper and cite their sources.
Background/Objectives: Whether age at type 1 diabetes (T1D) diagnosis reflects overall HLA class II epitope burden or additional sequence information remains unclear. We investigated whether HLA-DRB1 β57, a position in HLA-DR distinct from the established DQB1 β57 susceptibility position in HLA-DQ, contributes information about age at diagnosis beyond class II epitope burden. Methods: Phased DRB1–DQA1–DQB1 data were analysed in 97 early-onset T1D patients (EOT1D; ≤5 years) and 96 later-onset patients (LaOT1D; 8–30 years), recruited specifically within these age groups, and 169 controls from Portugal. Analyses included burden-adjusted multinomial models, complementary continuous-age regression, natural DRB1*04 sequence comparisons, and repeated nested cross-validation with independently tuned leave-one-position-out ablations; log loss was the primary cross-validation metric. Results: Epitope burdens distinguished T1D from controls but showed no statistically supported difference between EOT1D and LaOT1D. Adding DRB1 β57D improved multinomial fit (p = 2.28 × 10−8); the adjusted EOT1D-versus-LaOT1D relative risk ratio was 3.17 per copy (95% CI 1.65–6.09). DRB1 β57D dosage correlated inversely with age at diagnosis (ρ = −0.231; p = 0.0012) and was associated with diagnosis 2.28 years earlier per copy in the adjusted continuous-age model (95% CI −4.17 to −0.38; p = 0.0187). Expanded natural DRB1*04 comparisons involved β57, β71 and β86. Removing β57 increased cross-validated log loss by 0.0783 (Benjamini–Hochberg-adjusted q = 0.028) and reduced the area under the receiver operating characteristic curve from 0.6643 to 0.5134; no other removal survived correction in the primary patient comparison. Adjusted subgroup analyses did not establish an association after excluding *04:08/*04:05 carriers or among non-DR4 participants. Conclusions: Within this Portuguese cohort, DRB1 β57 contributed information about age at T1D diagnosis beyond the specified class II epitope burdens. These findings refine the previously observed DRB1*04 allele associations and warrant independent replication and functional investigation.
No takes yet. Share an insight, caveat, or question.
Paixão et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: